<SEC-DOCUMENT>0001304492-26-000038.txt : 20260717
<SEC-HEADER>0001304492-26-000038.hdr.sgml : 20260717
<ACCEPTANCE-DATETIME>20260717111432
ACCESSION NUMBER:		0001304492-26-000038
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260717
DATE AS OF CHANGE:		20260717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anterix Inc.
		CENTRAL INDEX KEY:			0001304492
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE COMMUNICATIONS (NO RADIO TELEPHONE) [4813]
		ORGANIZATION NAME:           	06 Technology
		EIN:				330745043
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36827
		FILM NUMBER:		261182396

	BUSINESS ADDRESS:	
		STREET 1:		3 GARRET MOUNTAIN PLAZA
		STREET 2:		SUITE 401
		CITY:			WOODLAND PARK
		STATE:			NJ
		ZIP:			07424
		BUSINESS PHONE:		(973) 771-0300

	MAIL ADDRESS:	
		STREET 1:		3 GARRET MOUNTAIN PLAZA
		STREET 2:		SUITE 401
		CITY:			WOODLAND PARK
		STATE:			NJ
		ZIP:			07424

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	pdvWireless, Inc.
		DATE OF NAME CHANGE:	20151105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pacific DataVision, Inc.
		DATE OF NAME CHANGE:	20140616

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Pacific Data Vision
		DATE OF NAME CHANGE:	20040928
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>atex-062026xdef14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ic8543e877f684b88abf9477c31bcf45a_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES&#160;AND&#160;EXCHANGE&#160;COMMISSION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SCHEDULE 14A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Amendment No.&#160;&#160;)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant&#160;&#160; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box&#58; </font></div><div style="margin-top:6pt"><font style="font-family:'Tahoma',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</font></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</font></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</font></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</font></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Material under &#167;240.14a-12</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%">Anterix&#160;Inc. </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Name of Registrant as Specified In Its Charter)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Payment of Filing Fee (Check all boxes that apply)&#58; </font></div><div><font style="font-family:'Tahoma',sans-serif;font-size:6pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:400;line-height:120%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:1.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</font></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">No fee required</font></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials</font></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&#160;0-11</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div id="ic8543e877f684b88abf9477c31bcf45a_632"></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">SUPPLEMENT TO PROXY STATEMENT DATED JUNE 25, 2026</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">FOR THE ANNUAL MEETING OF STOCKHOLDERS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">TO BE HELD ON AUGUST 4, 2026</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Anterix Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3 Garret Mountain Plaza </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Suite 401</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Woodland Park, NJ 07424</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Dear Stockholders,</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The additional information provided herein supplements, and should be read in conjunction with, the information regarding Proposal 3 - Amendment No. 2 to the 2023 Stock Plan (&#34;Proposal 3&#34;) contained in the definitive proxy statement (the &#34;Proxy Statement&#34;) of Anterix Inc. (&#34;we,&#34; &#34;us,&#34; &#34;our&#34; or the &#34;Company&#34;) filed with the Securities and Exchange Commission on June 25, 2026, regarding the annual meeting of stockholders to be held on August 4, 2026, at 9&#58;30 a.m. EDT (the &#34;2026 Annual Meeting&#34;). Except as supplemented by the information contained herein, all information set forth in the Proxy Statement remains unchanged. This supplement does not reflect any other events occurring after the date of the Proxy Statement or modify or update disclosures that may have been affected by subsequent events. From and after the date of this supplement, any references to the Proxy Statement will be deemed to include the Proxy Statement as supplemented hereby. Capitalized terms used herein, unless otherwise defined, have the meanings set forth in the Proxy Statement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As more specifically described in the Proxy Statement, we are seeking stockholder approval of Amendment No. 2 (the &#34;Amendment&#34;) to the Anterix Inc. 2023 Stock Plan (as amended from time-to-time, the &#34;2023 Plan&#34;), in order to increase the number of shares available for issuance under the 2023 Plan by 1.0 million shares. The Amendment was approved by the Company's Board of Directors (the &#34;Board&#34;) on June 22, 2026.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">On July 15, 2026, Institutional Shareholder Services (&#34;ISS&#34;) issued its Proxy Analysis &#38; Benchmark Policy Voting Recommendations (the &#34;ISS Report&#34;) related to our 2026 Annual Meeting. In the ISS Report, ISS recommended that stockholders vote against Proposal 3. The information below addresses the concerns outlined in the ISS Report and provides supplemental data to support Proposal 3 and the size of the share increase to 2023 Plan approved and recommended by the Board.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We are providing this additional information to help ensure that our stockholders have an opportunity to vote their shares on the basis of complete information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">The 2023 Plan share increase is reasonable.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Among the reasons provided by ISS for its negative voting recommendation was the determination by ISS that the size of the share increase (i.e., 1.0 million shares) we requested in Proposal 3 exceeded applicable ISS benchmarks. In reaching this determination, ISS utilized capitalization data as of March 31, 2026, the end of our 2026 fiscal year.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In determining the share increase request in Proposal 3, our Board considered capitalization data as of June 11, 2026 (the record date for the 2026 Annual Meeting), as outlined in the table below. In addition, we are providing supplemental information regarding the current overhang of our outstanding equity awards and the dilutive impact of our share increase request.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Correcting these assumptions and providing this supplemental information, we believe, will bring our share increase request within the parameters of ISS guidelines.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Updated 2023 Plan Details. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of June 11, 2026, there were a total of 279,420 shares of common stock that remained available for future awards under the 2023 Plan. Also as of June 11, 2026, there were 480,823 full value awards (e.g., RSUs, PSUs) and 1,518,488 appreciation awards (i.e., stock options and stock appreciation rights) outstanding. The weighted average exercise price and remaining term of such appreciation awards were $39.45 and 7.52 years, respectively.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.484%"><tr><td style="width:1.0%"></td><td style="width:74.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.050%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#1b6f80;border-left:1pt solid #181818;border-top:1pt solid #181818;padding:0 1pt"></td><td colspan="3" style="background-color:#1b6f80;border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">As of June 11, 2026</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#1b6f80;border-left:1pt solid #181818;padding:0 1pt"></td><td colspan="3" style="background-color:#1b6f80;border-right:1pt solid #181818;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Outstanding Stock Options</font></div></td><td colspan="3" style="border-right:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">1,518,488</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Weighted-average exercise price</font></div></td><td colspan="3" style="border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">$39.45</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Weighted-average remaining term (years)</font></div></td><td colspan="3" style="border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">7.52</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Full-value awards (e.g., RSUs, PSUs)</font></div></td><td colspan="3" style="border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">480,823</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Total Shares subject to outstanding awards</font></div></td><td colspan="3" style="border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">1,999,311</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Number of shares remaining available for grant</font></div></td><td colspan="3" style="border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">279,420</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Overhang</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">10.6%</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #181818;border-left:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Basic Dilution including new share request</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-bottom:1pt solid #181818;border-right:1pt solid #181818;border-top:1pt solid #181818;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">17.0%</font></div></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Overhang (number of shares subject to equity awards outstanding at maximum level but not exercised, plus number of shares available to be granted, divided by total shares of common stock outstanding at the end of the year plus the total number of shares available for issuance and outstanding awards) covers shares available prior to request and total shares subject to outstanding awards.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Basic dilution is the total number of shares subject to equity awards granted (at stretch level and less cancellations), including the new share request divided by the total shares of common stock outstanding.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:112%">THE BOARD REITERATES ITS RECOMMENDATION THAT YOU VOTE &#34;FOR&#34; THE APPROVAL OF PROPOSAL 3.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">If you have already voted, you do not need to vote again unless you would like to change or revoke your prior vote on any proposal. If you would like to change or revoke your prior vote on any proposal, please refer to page 6 of the Proxy Statement for instructions on how to do so.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Sincerely, </font></div><div style="text-align:justify"><img alt="gasa.jpg" src="gasa.jpg" style="height:41px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Gena L. Ashe</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Chief Legal Officer and Corporate Secretary</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Important Additional Information</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company, its directors and certain of its executive officers are participants in the solicitation of proxies from the Company&#8217;s stockholders in connection with the 2026 Annual Meeting. The Company filed the Proxy Statement and a proxy card with the SEC on June 25, 2026 in connection with any such solicitation of proxies from the Company&#8217;s stockholders. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH PROXY STATEMENT, ACCOMPANYING PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> The Company's Proxy Statement for the 2026 Annual Meeting contains information regarding the direct and indirect interests, by security holdings or otherwise, of the Company's directors and executive officers in the Company's securities. Information regarding subsequent changes to their holdings of the Company&#8217;s securities can be found in the SEC filings on Forms 3, 4 and 5, which are available on the Company&#8217;s website at https&#58;&#47;&#47;investors.anterix.com&#47;financials&#47;sec-filings or through the SEC&#8217;s website at www.sec.gov. Information can also be found in the Company's other SEC filings, including its Annual Report on Form 10-K for the year ended March 31, 2026, filed on June 25, 2026. Stockholders can obtain the Proxy Statement, any amendments or supplements to the Proxy Statement and other documents filed by the Company with the SEC at no charge at the SEC's website at www.sec.gov. Copies are also available at no charge on the Company's website at https&#58;&#47;&#47;investors.anterix.com&#47;financials&#47;sec-filings.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>gasa.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gasa.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  Z ,D# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**0]*
M L!1FFTAH ?D4;AZUC^*?$-MX6T*\U.[($,$9;&<;CT"CW)P*XGX&:AKGB#1
M=5UW6KJ24:A>,]I W"0PKP H].OXB@#TT,#1O%)UH[T .R*"<4W-% "[Q2Y%
M-HS0 N\4I8"FT4 .R* P--HH <6 H+ 4T'I10 [(I-XI** ' YI::M.H ***
M* "BBB@ I#TI:0]* &T454U34[;1["XO;N58+:",R22,>% H \?^/=_-K>N>
M'/"4#".WN2]]?S,<+%;Q\;B?KFN]^&/B72?$GAH_V+#+!8V,S6*K*FTG8 ,C
MV.<YKB=/\+:7XZ-]XZUV68A$=8K1)=B1VJ?,(Y5'4DC<1]*N>"O$VG_#CX5V
M>L:P6B_M"9KDI&NYG:5_E"K_ +NV@#U?'-+WK"U[QKI'AG1GU/4KR.UMT@-Q
MAV <H!DX7J3]*M6/B.QO=$M=6\]8+&XC65))SL^5A\N<].M &G130P=0RD$$
M=13NHH S8]>MY=;ETM"6N881-)QPH)P!GUKS7QKXYU75/B'H_ASP]<"$0W*&
M^D49++U9?8 =?KBK_P 3AJWA&YF\2Z#=6[7]S"ME]@NT++/(3^[*[>0PS^57
M?A5\,8_!%G+>7UP^H^(+XF:]O)/[[<LJ#LH/'X4 >@4@[T$XKC?'WB*]@FLM
M T1E_MO4R0LAY%M"/ORGZ#I[T 2^)?B;I/AJ9XY%N+L0LHNGM(_,6VR0 9#V
MZBNLC<2(&'((R#ZUY7XKT#3](T?2O!&FX-SJ]PK7#,<RO&K!Y97/4\@?G7J7
MF16X1&=4S\J@G&?84 /)Q2YS7$?%;QI)X1T)%LF3^UKUC%;;^0N!EG(]%']*
MU_ >H3:EX0TR[NKR*]GEA#27$6-KGUXXH Z T4U'650R,&4]"IR*=0 J=*=3
M5IU !1110 4444 %(>E+2'I0!1U:R?4=-NK>*XDM)9(V1)XOO1DCAA]*^<C\
M1=:U/Q#%X2\768N=-TN?;+J=JP6+4V7E5;. ,<%AGK7TS6==>'].O;1[:XLK
M>>W<EFCDB4J2>IQCK[T ?.%[X_MM*T_6/ Z13G5-8U-YC+9H9T%I(02^Y,@'
M VX..M7?%+:IXH^(.A64V@7MKHNGV0;3-.D3F[ER%W2$<1JH R#S7O\ H_AG
M2M 1UTVPM[$-][R(PN[ZXK3Q0!\N>.OAWJ'BOQ)JE_,L^JWN@6RR2[%.V6>4
MC,<:]"J1@X'K53QRVM_'7Q9_PB&E0WFA^']/MHPJ7,+1.Q*Y$K#^ZN  /6OJ
MN.%(RQ50I8Y) ZTBV\:S&0(HD8?,X')^IH \H\&?$9_#OAZP\.WND:M/XBLH
MA;/;+ S><5X$@D^[M/7.>]=O?>))_#OA*ZU?68XH)88S(T,;9"G^%,]SG S7
M2].:QO%?A:P\9:)/I.IQM+93X\Q%;:3@YZT >!Z=?>);[7=,\?ZMJ4MYH%M>
M+;M8,@$$6\[6G3O\A(7/?FOHR[OX+"U>YGE2*!!EI&.%'XU1N_"VG7OAV31'
MMU737A,'D*, +CM61HW@VZBT>71]:ODUG3 BQ11R1;7*@@C>>Y&!^5 '6(XD
M0,.5(R*\Q\-ZM9Q>(/''BC591"MA<G3D9_\ EG%$ <+_ +S'./6O3D01H%7@
M 8%<G=?"_0[WQ ^K2Q2F21Q+);>8?(DD'21DZ%O>@#Q;3/B;_8OB75_%NL>'
M-2DU^^N4TZTM)$VI:61/[N0N?E <G)K9O$FO?B;H]SXHUJ%9=+4ZC<0PR[+>
MTSQ%$O/SL>22>HZ5[CJVBV>NZ=-87]NES:3+LDBD&0PKD_#OP6\'^%[R2[L]
M&C:[D(9I[EVF8D=/O$].WI0!\[_$'Q;>_%WQ[J;:80OAFPDCT9+B0[#).Y^9
M>?NC/)/<#%>E_$36M/\ A;\+=/\ ".@W:/?,T-BD,#C>JNWSL<?=!R>3CK7I
MEI\,?#MII6I:;_9T<UIJ-T]Y=)+SYDK8RQ/7/ QZ5);_  U\-6NEW&GQZ/;"
MTN$\N52NXN/0L>?UH J^"[*W^'W@JTMM2O8;<1*6=YI<(A/.T%CT'2JI^(DW
MB*;[-X5L'U$$E6U*4%+6+\3RY]A3]-^#7A/3)%?^SC=LA^07DSS!!Z ,2/TK
ML[>WCM8EBA18HU&%1!@ >PH K:)9W-C8I'>71O+GJ\I& 3[#L*T*:M.H ***
M* "BBB@ I#TI:* &44^B@"+&:7M4E% $?6EI]% #**?10 RBGT4 1E12XI]%
A #**?10!'UI:?10 RBGT4 -7I3J** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
